Magnesium Glycinate and Claim Strategy: A Guide for U.S. Brands

Industry coverage from NutraIngredients-USA, SupplySide West, and leading formulation journals suggests growing familiarity and demand for magnesium across supplement and functional beverage categories.[1][2] For supplement manufacturers and functional beverage brands, the question is no longer whether to include magnesium. It is how to select a magnesium ingredient that supports both compliant product positioning and faster commercialization.

This article is written for procurement, formulation, regulatory, and product development teams evaluating magnesium glycinate for U.S. and international launches. It explains why claim strategy should be part of your ingredient selection criteria, and what to look for in a supplier that understands the regulatory and commercial environment.

The Market Context: Why Magnesium Glycinate Now?

The global magnesium supplement market was valued at approximately USD 1.45 billion in 2024, with projections reaching USD 2.1 billion by 2030.[3] Within this growth, magnesium glycinate and bisglycinate, chelated forms of magnesium, have emerged as a frequently selected option for premium positioning in sleep support, recovery, and daily wellness formulations.[1]U.S. consumers are increasingly educated about mineral bioavailability. Terms like 'absorption,' 'gentle on stomach,' and 'chelated' now appear in consumer-facing product descriptions and retail positioning.[1] This shift has created demand for magnesium ingredients that offer not only elemental content but also formulation flexibility, sensory performance, and documented quality.

MagneINNO Product Overview

MagneINNO™ supplies branded magnesium glycinate ingredients for supplement and beverage development. The 12%, 10%, and 8% grades are positioned for capsules and tablets, powders and sticks, and gummies and beverages respectively. Product-specific claims should be assessed against the actual composition, analytical evidence, intended use, and applicable market requirements.

MagneINNO is a specialized brand focused exclusively on high-quality chelated magnesium glycinate. All magnesium references in this article refer to MagneINNO's magnesium glycinate products, unless otherwise specified.

Why Claim Strategy Should Drive Your Ingredient Selection

Many ingredient projects slow down not because of supply issues, but because formulation, regulatory review, and marketing copy are handled as separate workstreams. The result: late-stage rework, delayed launches, and missed market windows.

A claim-aware ingredient strategy can help prevent this. When procurement, formulation, regulatory, and marketing teams align early on the product's core claim territory, the entire development process becomes more predictable. Here is what that alignment looks like in practice:

· Marketing defines the target consumer and the benefit territory before formulation begins.

· Regulatory maps the claim pathway by market and product category, identifying compliant language boundaries.

· Formulation designs the dosage, format, and sensory profile to support both the claim and the consumer experience.

· Procurement selects an ingredient supplier that can provide the documentation, consistency, and application support to execute the plan.

This is not theoretical. In companies where claim strategy is integrated into ingredient selection, the approach can reduce late-stage rework and improve launch predictability. In companies where it is treated as an afterthought, teams often find themselves rewriting labels, reformulating products, or resubmitting notifications. All of which can add cost and delay.

Regulatory Frameworks: What North American and EU Buyers Need to Know

European Union: Pre-Authorized Health Claims

In the EU, magnesium benefits from 10 authorized health claims under Commission Regulation (EU) No 432/2012,[6][7] covering normal muscle function, electrolyte balance, energy-yielding metabolism, nervous system function, psychological function, protein synthesis, maintenance of normal bones, maintenance of normal teeth, cell division, and reduction of tiredness and fatigue.

However, these claims apply to magnesium as a nutrient, not to any specific branded ingredient.[7][8] The finished product must meet conditions of use: at least 15% NRV under the applicable category rules (food, beverage, or supplement), which corresponds to ≥56.25 mg per 100 g, per 100 ml, or per serving for the 'source' claim.[7][8] The exact threshold depends on the product category. Beverage and supplement applications should be verified separately against the specific conditions in both Regulation (EU) No 432/2012 and Regulation (EC) No 1924/2006.[7][8] For U.S. brands planning EU expansion, this means your supplier's documentation must support the elemental magnesium content claims you intend to make.

A key advantage for brands: these 10 claims are pre-authorized by EFSA based on established scientific consensus.[6][7] Once your finished product meets the conditions of use (≥56.25 mg per serving for the "source" claim),[7][8] you can use the claim on your label without conducting additional clinical trials or submitting proprietary evidence. The regulatory work has already been done.

United States: Structure/Function Claims Framework

The U.S. framework is different. In some respects, it is more flexible, but also more self-regulated. For dietary supplements, structure/function claims are not pre-approved by FDA.[9][10] Instead, the manufacturer must:

· Ensure the claim is truthful, not misleading, and substantiated by competent and reliable scientific evidence.[9][11]

· Include the required disclaimer: 'This statement has not been evaluated by the Food and Drug Administration...'[9]

· Notify FDA within 30 days of first marketing the product with the claim.[9][10]

Compared to the EU's pre-authorized list, the U.S. system places more responsibility on the brand. But it also means that a well-documented ingredient with strong public-domain science, such as magnesium glycinate, can support a range of structure/function claims without requiring novel clinical trials for every product.[12][13]

The practical implication: U.S. brands should select magnesium ingredients from suppliers that provide robust documentation (COA, heavy metals testing, stability data, and chelation verification) to support the substantiation file, quality review, and any future FTC or FDA inquiry, rather than the 30-day notification itself, which is an administrative filing.

For well-established nutrient-function claims—such as "magnesium contributes to normal muscle function" or "supports energy metabolism"—brands can typically rely on publicly available scientific literature (e.g., NIH Office of Dietary Supplements fact sheets, EFSA scientific opinions, peer-reviewed reviews) for substantiation.[9][10] This means you do not need to conduct proprietary clinical trials for claims that describe broadly accepted nutrient roles. The substantiation requirement applies most strictly to novel or stretching claims that go beyond established science.[9][11]

Canada: CFIA and Health Canada Framework

Canada operates a dual-framework system. For foods, CFIA enforces nutrient function claims approved by Health Canada's Food Directorate. For natural health products (NHPs), Health Canada's Natural and Non-prescription Health Products Directorate (NNHPD) administers a separate pre-market licensing system.[14][15]

Under the food framework, the CFIA table lists the following acceptable nutrient function claims for magnesium, with exact wording required: 'contributes to normal muscle function' and 'factor in energy metabolism, tissue formation and bone development.'[14] Two additional generic claims also apply: 'Magnesium is a factor in the maintenance of good health' and 'Magnesium is a factor in normal growth and development.'[14] The food must contain at least 5% of the Daily Value (DV) for magnesium per serving, and the claim must appear in both English and French on the label.[14]

Under the NHP framework, Health Canada's Multi-Vitamin/Mineral Supplements Monograph authorizes specific claims for products that receive a Natural Product Number (NPN). The minimum effective dose is ≥20 mg elemental magnesium per day.[15][16] The monograph lists the following exact claim wordings: 'Helps in the development and maintenance of bones (and teeth).', 'Helps in energy metabolism (and) tissue formation.', 'Helps to maintain/support normal muscle function.', 'Helps to maintain/support normal electrolyte balance.', 'Helps to maintain/support the body's ability to metabolize nutrients.', and 'Helps to prevent magnesium deficiency.'[15][16] (The deficiency claim requires dosage at or above the RDA and is not permitted for children 1-8 years and adolescents 14-18 years.)[15][16]

For brands planning Canadian market entry, the distinction matters. Food products use CFIA-enforced nutrient function claims with the 5% DV threshold and must use the exact approved wording.[14] NHPs, including most supplements, follow Health Canada's monograph system with the ≥20 mg threshold, require pre-market licensing, and must use the exact claim wordings listed in the applicable monograph.[14][15][16]

A practical note on dosage thresholds: The NHP framework's ≥20 mg/day minimum is notably lower than the EU's ≥56.25 mg threshold (15% NRV).[14][15] For brands developing low-dose formats—such as gummies, functional beverages, or multi-nutrient formulas where magnesium is one of several actives—the Canadian threshold may be easier to meet while still supporting compliant claims. Both the CFIA food claims and Health Canada NHP claims are pre-approved; once your product meets the relevant threshold and uses the exact wording, no additional clinical evidence is required from the brand.[14][15][16]

Evaluate the ingredient in the intended format

Compare candidate materials using their declared composition and an equal elemental magnesium target. Record the resulting ingredient mass, and evaluate capsule filling, drink preparation, sensory attributes, or other relevant properties in the actual formula. The results can support a formulation decision within the tested conditions. They do not independently establish a clinical or absorption claim.

Reviewing the analytical evidence

A useful technical package identifies the question each method addresses, the material and reference used, and the acceptance criteria. Total elemental magnesium, material identity, water content, and any separately defined free or unbound fraction are different analytical questions.

MagneINNO's technical platform references ICP-OES, complexometric titration, FTIR, XRD, TGA, DSC, and Karl Fischer. Confirm the applicable methods and available data for the grade and lot under review. Listing several instruments does not establish complete chelation, a fixed testing scope for every lot, or superiority over another supplier.

Common Mistakes in Magnesium Ingredient Marketing

Example 1: Confusing Nutrient Claims with Finished-Product Claims

One of the most frequent errors is treating an authorized nutrient claim as if it were a blanket approval for any product containing that nutrient. The claim authorizes the nutrient's role; the finished product must still meet all conditions of use. For brands selling to consumers, this distinction shapes what can and cannot appear on the label.[7][8][9]

Compliant consumer-facing language:

Magnesium contributes to normal muscle function. This product provides 60 mg of elemental magnesium per serving (16% DV).

Riskier language that overstates regulatory meaning:

This supplement is officially approved to improve your muscle function.

The second version creates avoidable review risk. Under EU law, claims authorize the nutrient, not the product. Under U.S. law, structure/function claims describe the role of a dietary ingredient, not a guaranteed outcome for the consumer. The finished product must meet the specific conditions of use—dosage, format, and target population—for the claim to be valid.[7][8][9]

Example 2: Stretching into Disease/Treatment Territory

Even in educational content, brands should avoid stretching nutrient-function language into disease or treatment claims. EFSA has explicitly rejected magnesium claims for blood pressure maintenance, blood glucose regulation, immune function, oxidative damage protection, and mental stress resistance.[6] In the U.S., such language may trigger drug-claim classification under 21 CFR 101.93(g).[9]

Terms like 'prevents cramps,' 'treats muscle problems,' 'cures insomnia,' or 'reduces anxiety' should be avoided unless the claim is specifically permitted and substantiated in the relevant market.[6][9]

Cross-Functional Alignment: What Each Team Should Confirm Before Launch

Claim strategy is not a regulatory-only concern. It is a cross-functional coordination point that affects timeline, budget, and commercial outcome. Here is what each function should clarify early in the development process:

Marketing & Product Development

· Who is the target consumer, and what specific need state are we addressing? (e.g., daily wellness, sleep support, athletic recovery)

· What is the core claim territory, and does it align with regulatory frameworks in our target markets?

· Have we validated that our intended messaging stays within nutrient-function language and does not drift into disease/treatment claims?

Regulatory & Quality Assurance

· Which markets are we launching in first, and what are the specific claim requirements for each?

· Does our supplier provide documentation that supports the elemental magnesium content and purity claims we need?

· Have we prepared the required FDA notification (U.S.) or confirmed EU conditions of use compliance?

Formulation & R&D

· What is the target elemental magnesium per serving, and can our selected ingredient grade achieve it within the dosage format constraints?

· Does the ingredient's taste, solubility, and stability profile match our delivery system (capsule, powder, gummy, beverage)?

· Have we confirmed compatibility with other active ingredients in the formula?

Procurement & Supply Chain

· Can the supplier provide consistent batch-to-batch quality, with COA and heavy metals documentation?

· Is the supplier's capacity and inventory position aligned with our production forecast?

· Does the supplier offer application support (particle size, flowability, solubility data) for our specific product format?

Ingredient documentation and supply

MagneINNO™ supplies branded magnesium glycinate manufactured in China and stocked in California. We coordinate specifications, batch documentation, samples, and project-specific commercial information. Request the current facility records and read each document within its actual scope; facility registration does not establish NSF Certified for Sport product certification.

Select a grade against the finished-product brief and assess its behavior in the intended formula. Any comparative sensory, tolerability, or absorption claim needs evidence appropriate to the actual material and wording. Discuss your documentation and sample requirements.

Next Steps

If your team is planning a magnesium glycinate launch and needs to evaluate ingredient fit, documentation requirements, or claim strategy for the U.S., Canadian, or EU markets, contact MagneINNO for a technical consultation.

Email: sales@magneinno.com | Website: https://www.magneinno.com | LinkedIn: https://www.linkedin.com/company/magneinno/

Disclaimer

This article is for general industry information only. It does not constitute legal, regulatory, or medical advice. Labeling and advertising requirements vary by market, product category, claim type, and finished-product composition. Review all claims with qualified regulatory counsel before use.

References

[1] Source: Trade publication reporting. NutraIngredients-USA, 2023-2024.

[2] Source: Conference reporting. SupplySide West, Las Vegas, October 2025.

[3] Source: Industry market research. Grand View Research. Magnesium Supplement Market Size Report, 2024-2030. https://www.grandviewresearch.com/industry-analysis/magnesium-supplement-market

[6] EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of health claims related to magnesium. EFSA Journal 2010;8(10):1807. https://doi.org/10.2903/j.efsa.2010.1807

[7] Commission Regulation (EU) No 432/2012 of 16 May 2012 establishing a list of permitted health claims made on foods. Official Journal of the European Union. https://eur-lex.europa.eu/eli/reg/2012/432/oj

[8] Regulation (EC) No 1924/2006 of the European Parliament and of the Council on nutrition and health claims made on foods. Official Journal of the European Union. https://eur-lex.europa.eu/eli/reg/2006/1924/oj

[9] U.S. Food and Drug Administration. Structure/Function Claims for Dietary Supplements. 21 CFR 101.93. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-101/subpart-F/section-101.93

[10] U.S. Food and Drug Administration. Notifications for Structure/Function Claims for Dietary Supplements. https://www.fda.gov/food/information-industry-dietary-supplements/notifications-structurefunction-and-related-claims-dietary-supplement-labeling

[11] Federal Trade Commission. Health Products Compliance Guidance. https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance

[12] NIH Office of Dietary Supplements. Magnesium: Fact Sheet for Health Professionals. Updated March 2024. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/

[13] U.S. Food and Drug Administration. Dietary Supplement Labeling Guide: Chapter VI - Claims. https://www.fda.gov/food/dietary-supplements-guidance-documents-regulatory-information/dietary-supplement-labeling-guide-chapter-vi-claims

[14] Canadian Food Inspection Agency (CFIA) & Health Canada. Table of acceptable nutrient function claims: Magnesium. https://inspection.canada.ca/en/food-labels/labelling/industry/health-claims

[15] Health Canada. Natural Health Products Ingredients Database: Magnesium in Magnesium bisglycinate (NHPID ID 991). https://webprod.hc-sc.gc.ca/nhpid-bdipsn/singredReq?id=991

[16] Health Canada. Multi-Vitamin/Mineral Supplements Monograph. Magnesium claims and dosage requirements. https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl